Open AccessOne-year outcomes of a NeoHexa sirolimus-eluting coronary stent system with a biodegradable polymer in all-comers coronary artery disease patients: Results from NeoRegistry in India
Author(s) -
Rajagopal Jambunathan,
Dinesh Basavanna,
Preeti Vani,
Malte Neuss,
Prashant Janbandhu
Publication year - 2019
Publication title -
world journal of cardiology
Language(s) - English
Resource type - Journals
ISSN - 1949-8462
DOI - 10.4330/wjc.v11.i8.200
Subject(s) - medicine , mace , restenosis , myocardial infarction , coronary artery disease , stent , cardiology , target lesion , thrombosis , drug eluting stent , clinical endpoint , revascularization , surgery , percutaneous coronary intervention , clinical trial
Biodegradable polymer drug-eluting stents (BP-DES) have shown to reduce restenosis rates and have low rates of stent thrombosis. The present postmarketing surveillance assessed 1-year clinical outcomes of patients who had received NeoHexa DES in real practice.